Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2026)

Zai Lab (ZLAB) posted Asset Writedowns and Impairment of $188000.0 for Q1 2026, down 98.35% sequentially from $11.4 million in Q4 2025, and up 596.3% YoY from $27000.0 in Q1 2025.

Analysis

Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

Zai Lab has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $188000.0 in Q1 2026.

  • Quarterly Asset Writedowns and Impairment rose 596.3% year-over-year to $188000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 1446.46% YoY) and the FY2025 annual result came in at $12.3 million, up 1407.73% from the prior year.
  • Asset Writedowns and Impairment eased to $188000.0 in Q1 2026 per ZLAB's latest filing, from $11.4 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $11.4 million in Q4 2025 and troughed at -$3000.0 in Q4 2022.
  • A 5-year average of $867117.6 and a median of $188000.0 in 2026 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment tumbled 100.31% in 2022, then jumped 1136800.0% in 2025.
  • Over 5 years, Asset Writedowns and Impairment stood at -$3000.0 in 2022, then jumped by 7666.67% to $227000.0 in 2023, then sank by 99.56% to $1000.0 in 2024, then surged by 1136800.0% to $11.4 million in 2025, then slumped by 98.35% to $188000.0 in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $188000.0, $11.4 million, and $625000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.89 Mn
Mar 31, 2026 188,000.00
Dec 31, 2025 11.37 Mn
Sep 30, 2025 625,000.00
Jun 30, 2025 267,000.00
Mar 31, 2025 27,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 58,000.00
Jun 30, 2024 719,000.00
Mar 31, 2024 37,000.00
Dec 31, 2023 227,000.00
Sep 30, 2023 123,000.00
Jun 30, 2023 246,000.00
Mar 31, 2023 377,000.00
Dec 31, 2022 -3,000.00
Sep 30, 2022 287,000.00
Jun 30, 2022 55,000.00
Mar 31, 2022 138,000.00
Dec 31, 2021 966,000.00
Sep 30, 2021 112,000.00